Drawing for SOQLADIC

USPTO serial 99728947

SOQLADIC

Reviewed by CopyMark Law Group

Status 653
Filing date
Status date
Registration date
—
Examiner
BROWNING, KATHRYN ELISABETH
Law office
TMO LAW OFFICE 124

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SOQLADIC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Leonid Rakitin

Leonid Rakitin AstraZeneca Pharmaceuticals LP950 Wind River LaneGaithersburg, MD 20878United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Vaccines; Antibodies for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 6, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 6, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 6, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 6, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 6, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Jun 6, 2026CNSLSUSPENSION LETTER WRITTEN—
Jun 5, 2026DOCKASSIGNED TO EXAMINER—
Mar 27, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 27, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 27, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance